机构风向标 | 冠昊生物(300238)2025年三季度已披露持仓机构仅6家

Core Viewpoint - Guanhao Bio (300238.SZ) reported its Q3 2025 results, highlighting a total institutional ownership of 75.83 million shares, representing 28.60% of the company's total equity, with a slight decrease in institutional ownership compared to the previous quarter [1] Institutional Ownership - As of October 28, 2025, six institutional investors disclosed their holdings in Guanhao Bio, with a combined ownership of 75.83 million shares, accounting for 28.60% of total shares [1] - The total institutional ownership decreased by 0.74 percentage points compared to the previous quarter [1] Public Fund Holdings - One public fund, the Medical Device ETF, increased its holdings during this period, with an increase in ownership percentage of 0.28% [1] - A total of 33 public funds that did not disclose their holdings in the previous quarter include notable names such as CITIC Securities Rotation Mixed A and CITIC Securities Selected Mixed A [1] Foreign Investment - The report indicates that BARCLAYS BANK PLC is the foreign institution that did not disclose its holdings in this quarter compared to the previous one [1]